Popular Articles

Govt to issue oil bonds worth Rs 10,300 cr to IOC, BPCL, HPCL
The government may issue Indian Oil Corporation (IOC), Bharat Petroleum Corporation Limited (BPCL) and Hindustan Petroleum Corporation Limited (HPCL) Rs 10,300 crore worth of oil bonds this week to compensate these companies for the losses they have incurred on fuel sales in last fiscal.

Govt asks SFIO to start prosecution in Satyam case
The government today asked investigating agency Serious Fraud Investigation Office (SFIO) to initiate prosecution proceedings against persons involved in Satyam accounting fraud and partners of Price Waterhouse, the auditors of the IT company.

News of the day

'The slowdown won't affect good talent'
Aptech has so far trained five million students globally and has over 1,000 centres in 35 countries. In his first interview to the media after taking over as CEO and managing director, Ninad Karpe tells Shivani Shinde how he plans to take the company into the next phase of growth. Edited excerpts:
Business Opportunities

DCGI to issue CoPP & WHO certificates for export from October

The Drug Controller General of India from next month will issue Certificates of Pharmaceutical Products (CoPP) and Certificates of Good Manufacturing Practice for medicinal products required for exports. - Process Cipla"s licence for "Soranib": HC - Latha Jishnu: Setting aside Bayer"s "spurious" claims">Latha Jishnu: Setting aside Bayer"s "spurious" claims - Venus Remedies gets DCGI nod for selling Mebatic - GSK plans to launch H1N1 drug in India - Bayer"s attempt to stop Cipla drug sale fails - Allow retail sale of drug, say domestic pharma players In a letter to various stake holders, DCGI said, "a considered view has been taken that Certificate of Pharmaceutical Products (CoPP) and Certificate of Good Manufacturing Practise (GMP) under WHO certification shall be taken over by the National Regulatory Authority ie DCGI office." The notification on the centralisation of the process said both the CoPPs and the GMPs would be issued from October 1 by the national drug regulator. The CoPP is mandatory in many countries that require World Health Organisation (WHO) accreditation for pharmaceutical products being imported. As laid down by the WHO, the GMP certification is also necessary for the same. The decision was made in 40th drug consultative committee (DCC) meeting held in June, after WHO raised several issues over the issuance of these certificates. "The WHO has time and again expressed concerns on the implementation of the WHO certification scheme on the quality of pharmaceutical products moving in international commerce," the letter said.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):